Objective. To assess the relative radiographic conspicuity of gadolinium-based contrast agents (GBCAs) that may be used in spinal injection procedures when iodine-based contrast agents are contraindicated.
Introduction
Injection of contrast media is essential for the safe and accurate performance of spinal injection procedures. Contrast medium serves to exclude distribution to unwanted compartments (intravascular, intradural, subdural, intrathecal) and to characterize appropriate epidural or intra-articular flow. Although acute adverse reactions to administration of low-osmolar iodinated contrast media are infrequent (0.2-0.6%), it is prudent to avoid iodinated contrast when there is a history of prior reaction [1] . Gadolinium-based contrast agents (GBCA) offer an alternative, but radiodensity is reduced and varies by preparation [2, 3] . We undertook a study to quantify the relative radiodensity of GBCAs available as alternatives to iodine-based contrast.
Methods
Eight gadolinium and three iodine contrast agents were selected for imaging (Table 1) . One and one-half milliliters of contrast material was drawn up into a 3 cc syringe and then dispensed into a syringe cap to a depth of approximately 5 mm. These caps were then placed within an acrylic/aluminum phantom simulating an adult abdomen (21 cm equivalent thickness). These agents were imaged on a 30x38 cm flat-panel Multi-Diagnost Eleva C-arm single-plane fluoroscopy system (Philips Medical Systems, Best, the Netherlands) using the 31 cm field of view, a single shot digital acquisition, and varying kVp (70, 90, 109, and 125 kVp). Radiographic contrast of each agent was measured as the percent pixel value difference with respect to background measured at the center of each image using a circular region of interest ( Figure 1 ).
Results
Gadobutrol had the highest radiodensity among the gadolinium agents tested. Relative radiographic contrast values are shown in Figure 2 for 70 kVp x-ray beam energy. Other beam energies tested showed a similar relationship. Note that radiographic contrast levels of each agent are roughly proportional to their molar concentration. The contrast of all agents tested was found to decrease with increasing kVp. As shown in Figure 3 , iodine has a sharper decrease in contrast with beam energy as compared with gadobutrol (similarly seen for the other gadolinium agents tested). Within the range of kVps tested (70-125 kVp), gadobutrol radiographic contrast lies between iohexol concentrations of 240 and 140 mgI/mL.
Discussion
When confronted with a patient with a clear history of adverse reaction to iodinated contrast media, the choices become: 1) premedication, requiring rescheduling and adding to the steroid burden; 2) performing the procedure without contrast media, compromising both safety and efficacy, especially for transforaminal injections; 3) use of a GBCA. Gadobutrol will provide a density of modestly less than iohexol 240 at kVp ranges typically used for adult patients. The conspicuity of agents of lesser radiodensities can be enhanced with digital subtraction imaging. This may be appropriate for epidural procedures, but may not be necessary for intra-articular injections.
The sharper decrease in contrast with increasing beam energy for iodine, as compared with GBCA, shown in Figure 3 , can be explained by the lower k-edge of iodine (33 keV) compared with that for gadolinium (50 keV), which results in a more significant reduction in attenuation at higher beam energies. The k-edge is the amount of energy needed to eject a K-shell electron (the innermost and most strongly bound electrons). When x-rays interact with the contrast agent, the probability of interaction increases greatly for x-rays with energies just above the k-edge energy. As the x-ray beam kVp increases, the low-energy portion of the beam spectrum decreases sharply, resulting in a sharp decrease in attenuation for iodine. Due to gadolinium's higher k-edge energy, it is less affected by this change in the beam spectrum. This reduced dependence on kVp for gadolinium agents will be paradoxically more apparent in larger patients, where the automatic exposure control will increase the kVp and result in contrast levels comparable with iodine agents [4] . The conspicuity of all contrast agents will be improved by using lower kVp, at the cost of a higher radiation dose.
It must be noted that epidural use of GBCA is an offlabel utilization unapproved by the US Food and Drug Administration. The interventionalist should be particularly wary of potential intrathecal delivery of GBCA, Figure 2 Relative radiographic contrast of gadolinium contrast agents at 70 kVp. Molar concentration of each agent is listed. Figure 3 Relative radiographic contrast of gadobutrol and iohexol contrast agents vs peak tube potential (kVp).
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especially with 1 mM/mL gadobutrol. Although MRI myelography with 0.5-1.0 mL (0.25-0.5 mM) of gadopentetate dimeglumine has been reported without significant adverse effects, higher intrathecal doses of GBCA (misadministrations) have caused significant neurotoxicity [5, 6] . Use in interlaminar epidural injections may be ill advised, and any suspicion of intrathecal flow should terminate the procedure.
